When your patients are looking to understand if they are a carrier for specific genetic conditions like cystic fibrosis, spinal muscular atrophy, fragile X syndrome, or Tay-Sachs disease, appropriate genetic screening and actionable results are essential.
As patients consider starting a family, they may want to have a better understanding of their genetic makeup, and whether they are at increased risk of passing along a genetic variant to their children. Genetic carrier screening is a crucial tool to help couples have a better understanding of risk and guide their family planning decisions.
Designed with the guidelines from the American College of Obstetricians and Gynecologists (ACOG) in mind, Quest’s experiencedboard-certified genetic counselors and scientists developed pan-ethnic QHerit® carrier screening to provide you and your patients with important insights into relevant conditions that can impact healthcare planning decisions.
Alpha-thalassemia, Beta-hemoglobinopathies (including sickle cell disease), Bloom syndrome, Canavan disease, Cystic fibrosis, Dihydrolipoamide dehydrogenase deficiency, Familial dysautonomia, Familial hyperinsulinism, ABCC8-related, Fanconi anemia, type C, Fragile X syndromed, Gaucher disease, Glycogen storage disease, type 1A, Joubert syndrome 2, Maple syrup urine disease, 1B, Mucolipidosis, type 4, Nemaline myopathy, Niemann-Pick disease, types A & B, Spinal muscular atrophy, Tay-Sachs disease, Usher syndrome, type 1F, Usher syndrome, type 3A, Walker-Warburg syndrome
Please note that Quest offers a variety of single gene and gene panel testing. For the genetic panel noted in this document, there may be single gene tests or smaller panels that may be applicable for your patient. Refer to the Quest Diagnostics Test Directory for further information.
As part of our commitment to provide clinically relevant, right-sized solutions, our QHerit® product portfolio has been designed to help you understand your patient’s genetic risks and support family planning discussions.
Ever-evolving, our QHerit panels are designed with the American College of Obstetricians and Gynecologists (ACOG) guidelines and the American College of Medical Genetics and Genomics (ACMG) practice resource in mind. We currently offer 4 screening panel options for up to 421 diseases to help you to select a medically appropriate panel based on your patient’s needs.
22 diseases
24 genes
84 diseasesc
85 genes
150 diseasesc
150 genes
421 diseasesc
421 genes
The most common diseases, including cystic fibrosis (CF), spinal muscular atrophy (SMA), fragile X, and Tay-Sachs
22 diseases
24 genes
84 diseasesc
85 genes
150 diseasesc
150 genes
421 diseasesc
421 genes
a Based on Quest Diagnostics 2021 fiscal year national claims analysis.
b QHerit panels are screening tests. QHerit does not diagnose a disease or disorder.
c Panel components for males do not include specified X-linked diseases.
Please note that Quest offers a variety of single-gene and gene panel testing. For the genetic panel noted in this document, there may be single-gene tests or smaller panels that may be applicable for your patient. Refer to the Quest Diagnostics Test Directory for further information.
We understand that you and your patients depend on these results for prenatal planning and care. The QHerit carrier screening portfolio provides medically appropriate and accessible information that you and your patients need to optimize prenatal care decisions.
At Quest Advanced® Women’s Health, we understand that you and your patients depend on these results for family planning and care. QHerit provides medically appropriate and clinically relevant insights that you and your patients need to help plan their futures.
We believe cost shouldn’t be a barrier to care. We are committed to keeping costs low so that more patients, regardless of their financial status, can access the screening they need.
a Based on Quest Diagnostics 2021 fiscal year national claims analysis.
d This is directional data. It is based on 2020 HealthLeaders membership data of private third-party payers at the Managed Care Organization (MCO) level, as well as Quest internal data. Information is believed to be accurate as of January 1, 2020; however, it is subject to change. Does not include Kaiser Permanente access data.
Alpha-thalassemia(HBA1/HBA2)
Beta hemoglobinopathies(HBB)
Bloom syndrome(BLM)
Canavan disease(ASPA)
Cystic fibrosis(CFTR)
Dihydrolipoamide dehydrogenase deficiency(DLD)
Familial dysautonomia(ELP1 (AKA:IKBKAP))
Familial hyperinsulinism, ABCC8-related(ABCC8)
Fanconi anemia, Group C(FANCC)
Fragile X syndromee(FMR1)
Gaucher disease(GBA)
Glycogen storage disease, type Ia(G6PC (AKA:G6PC1))
Joubert syndrome 2(TMEM216)
Maple syrup urine disease, type 1B(BCKDHB)
Mucolipidosis, type IV(MCOLN1)
Nemaline myopathy 2(NEB)
Niemann-Pick disease, types A/B(SMPD1)
Spinal muscular atrophy(SMN1)
Tay-Sachs disease(HEXA)
Usher syndrome, type 1F(PCDH15)
Usher syndrome, type 3A(CLRN1)
Fukuyama congenital muscular dystrophy (Walker-Warburg)(FKTN)
Alpha-thalassemia(HBA1/HBA2)
Beta hemoglobinopathies(HBB)
Bloom syndrome(BLM)
Canavan disease(ASPA)
Cystic fibrosis(CFTR)
Dihydrolipoamide dehydrogenase deficiency(DLD)
Familial dysautonomia(ELP1 (AKA:IKBKAP))
Familial hyperinsulinism, ABCC8-related(ABCC8)
Fanconi anemia, Group C(FANCC)
Fragile X syndromee(FMR1)
Gaucher disease(GBA)
Glycogen storage disease, type Ia(G6PC (AKA:G6PC1))
Joubert syndrome 2(TMEM216)
Maple syrup urine disease, type 1B(BCKDHB)
Mucolipidosis, type IV(MCOLN1)
Nemaline myopathy 2(NEB)
Niemann-Pick disease, types A/B(SMPD1)
Spinal muscular atrophy(SMN1)
Tay-Sachs disease(HEXA)
Usher syndrome, type 1F(PCDH15)
Usher syndrome, type 3A(CLRN1)
Fukuyama congenital muscular dystrophy (Walker-Warburg)(FKTN)
Abetalipoproteinemia(MTTP)
Adrenoleukodystrophy, X-linkede(ABCD1)
Argininosuccinic aciduria(ASL)
Ataxia-telangiectasia(ATM)
Autosomal recessive polycystic kidney disease(PKHD1)
Bardet-Biedl syndrome 1(BBS1)
Bardet-Biedl syndrome 2(BBS2)
Biotinidase deficiency(BTD)
Carnitine palmitoyltransferase II deficiency(CPT2)
Cerebrotendinous xanthomatosis(CYP27A1)
Citrullinemia, type I(ASS1)
Combined pituitary hormone deficiency, type 2(PROP1)
Congenital amegakaryocytic thrombocytopenia(MPL)
Congenital disorder of glycosylation, type Ia(PMM2)
Cystinosis(CTNS)
D-bifunctional protein deficiency(HSD17B4)
Factor XI deficiency / Hemophilia C(F11)
Familial Mediterranean fever(MEFV)
Galactosemia(GALT)
Glutaric acidemia, type I(GCDH)
Glycogen storage disease, type II / Pompe disease(GAA)
Glycogen storage disease, type III(AGL)
Glycogen storage disease, type IV / Adult polyglucosan body disease(GBE1)
GRACILE syndrome(BCS1L)
Hereditary fructose intolerance(ALDOB)
Hermansky-Pudlak syndrome, type 1(HPS1)
Hermansky-Pudlak syndrome, type 3(HPS3)
Hypophosphatasia(ALPL)
Krabbe disease(GALC)
Limb-girdle muscular dystrophy, type 2A(CAPN3)
Limb-girdle muscular dystrophy, type 3(SGCA)
Long chain 3-hydroxyacyl-coa dehydrogenase deficiency(HADHA)
Maple syrup urine disease, type 1A(BCKDHA)
Medium chain acyl-CoA dehydrogenase deficiency(ACADM)
Metachromatic leukodystrophy, ARSA-related(ARSA)
Combined methylmalonic aciduria and homocystinuria, cblC type / Cobalamin C deficiency(MMACHC)
Mucolipidosis II and mucolipidosis III alpha/beta(GNPTAB)
Mucopolysaccharidosis, type I / Hurler syndrome(IDUA)
Mucopolysaccharidosis, type IIIA / Sanfilippo syndrome A(SGSH)
Steroid resistant nephrotic syndrome, type 1(NPHS1)
Neuronal ceroid lipofuscinosis, CLN3-related(CLN3)
Neuronal ceroid lipofuscinosis, CLN5-related(CLN5)
Neuronal ceroid lipofuscinosis, CLN8-related(CLN8)
Neuronal ceroid lipofuscinosis, PPT1-related(PPT1)
Neuronal ceroid lipofuscinosis, TPP1-related(TPP1)
Nijmegen breakage syndrome(NBN)
Nonsyndromic hearing loss and deafness (DFNB) 1(GJB2)
Ornithine transcarbamylase deficiency, X-linkede(OTC)
Pendred syndrome(SLC26A4)
Phenylalanine hydroxylase deficiency(PAH)
Primary hyperoxaluria, type I(AGXT)
Propionic acidemia, PCCA-related(PCCA)
Propionic acidemia, PCCB-related(PCCB)
Sjögren-Larsson syndrome(ALDH3A2)
Skeletal dysplasias, SLC26A2-related(SLC26A2)
Smith-Lemli-Opitz syndrome(DHCR7)
Carnitine deficiency, systemic primary(SLC22A5)
Tyrosinemia, type I(FAH)
Usher syndrome, type 2A(USH2A)
Very long-chain acyl-CoA dehydrogenase deficiency(ACADVL)
Wilson disease(ATP7B)
Zellweger spectrum disorders, PEX2-related(PEX2)
Alpha-thalassemia(HBA1/HBA2)
Beta hemoglobinopathies(HBB)
Bloom syndrome(BLM)
Canavan disease(ASPA)
Cystic fibrosis(CFTR)
Dihydrolipoamide dehydrogenase deficiency(DLD)
Familial dysautonomia(ELP1 (AKA:IKBKAP))
Familial hyperinsulinism, ABCC8-related(ABCC8)
Fanconi anemia, Group C(FANCC)
Fragile X syndromee(FMR1)
Gaucher disease(GBA)
Glycogen storage disease, type Ia(G6PC (AKA:G6PC1))
Joubert syndrome 2(TMEM216)
Maple syrup urine disease, type 1B(BCKDHB)
Mucolipidosis, type IV(MCOLN1)
Nemaline myopathy 2(NEB)
Niemann-Pick disease, types A/B(SMPD1)
Spinal muscular atrophy(SMN1)
Tay-Sachs disease(HEXA)
Usher syndrome, type 1F(PCDH15)
Usher syndrome, type 3A(CLRN1)
Fukuyama congenital muscular dystrophy (Walker-Warburg)(FKTN)
Abetalipoproteinemia(MTTP)
Adrenoleukodystrophy, X-linkede(ABCD1)
Argininosuccinic aciduria(ASL)
Ataxia-telangiectasia(ATM)
Autosomal recessive polycystic kidney disease(PKHD1)
Bardet-Biedl syndrome 1(BBS1)
Bardet-Biedl syndrome 2(BBS2)
Biotinidase deficiency(BTD)
Carnitine palmitoyltransferase II deficiency(CPT2)
Cerebrotendinous xanthomatosis(CYP27A1)
Citrullinemia, type I(ASS1)
Combined pituitary hormone deficiency, type 2(PROP1)
Congenital amegakaryocytic thrombocytopenia(MPL)
Congenital disorder of glycosylation, type Ia(PMM2)
Cystinosis(CTNS)
D-bifunctional protein deficiency(HSD17B4)
Factor XI deficiency / Hemophilia C(F11)
Familial Mediterranean fever(MEFV)
Galactosemia(GALT)
Glutaric acidemia, type I(GCDH)
Glycogen storage disease, type II / Pompe disease(GAA)
Glycogen storage disease, type III(AGL)
Glycogen storage disease, type IV / Adult polyglucosan body disease(GBE1)
GRACILE syndrome(BCS1L)
Hereditary fructose intolerance(ALDOB)
Hermansky-Pudlak syndrome, type 1(HPS1)
Hermansky-Pudlak syndrome, type 3(HPS3)
Hypophosphatasia(ALPL)
Krabbe disease(GALC)
Limb-girdle muscular dystrophy, type 2A(CAPN3)
Limb-girdle muscular dystrophy, type 3(SGCA)
Long chain 3-hydroxyacyl-coa dehydrogenase deficiency(HADHA)
Maple syrup urine disease, type 1A(BCKDHA)
Medium chain acyl-CoA dehydrogenase deficiency(ACADM)
Metachromatic leukodystrophy, ARSA-related(ARSA)
Combined methylmalonic aciduria and homocystinuria, cblC type / Cobalamin C deficiency(MMACHC)
Mucolipidosis II and mucolipidosis III alpha/beta(GNPTAB)
Mucopolysaccharidosis, type I / Hurler syndrome(IDUA)
Mucopolysaccharidosis, type IIIA / Sanfilippo syndrome A(SGSH)
Steroid resistant nephrotic syndrome, type 1(NPHS1)
Neuronal ceroid lipofuscinosis, CLN3-related(CLN3)
Neuronal ceroid lipofuscinosis, CLN5-related(CLN5)
Neuronal ceroid lipofuscinosis, CLN8-related(CLN8)
Neuronal ceroid lipofuscinosis, PPT1-related(PPT1)
Neuronal ceroid lipofuscinosis, TPP1-related(TPP1)
Nijmegen breakage syndrome(NBN)
Nonsyndromic hearing loss and deafness (DFNB) 1(GJB2)
Ornithine transcarbamylase deficiency, X-linkede(OTC)
Pendred syndrome(SLC26A4)
Phenylalanine hydroxylase deficiency(PAH)
Primary hyperoxaluria, type I(AGXT)
Propionic acidemia, PCCA-related(PCCA)
Propionic acidemia, PCCB-related(PCCB)
Sjögren-Larsson syndrome(ALDH3A2)
Skeletal dysplasias, SLC26A2-related(SLC26A2)
Smith-Lemli-Opitz syndrome(DHCR7)
Carnitine deficiency, systemic primary(SLC22A5)
Tyrosinemia, type I(FAH)
Usher syndrome, type 2A(USH2A)
Very long-chain acyl-CoA dehydrogenase deficiency(ACADVL)
Wilson disease(ATP7B)
Zellweger spectrum disorders, PEX2-related(PEX2)
Beta-ketothiolase deficiency(ACAT1)
3-methylcrotonyl-CoA carboxylase 1 deficiency(MCCC1)
3-methylcrotonyl-CoA carboxylase 2 deficiency(MCCC2)
6-pyruvoyl-tetrahydropterin synthase deficiency(PTS)
Adenosine deaminase deficiency(ADA)
Alpha-mannosidosis(MAN2B1)
Alport syndrome, COL4A3-related(COL4A3)
Alport syndrome, COL4A4-related(COL4A4)
Alport syndrome, COL4A5-related, X-linkede(COL4A5)
Agenesis of the corpus callosum with peripheral neuropathy(SLC12A6)
Arthrogryposis, mental retardation, and seizures(SLC35A3)
Aspartylglycosaminuria(AGA)
Menkes diseasee(ATP7A)
Autoimmune polyglandular syndrome, type 1(AIRE)
Spastic ataxia, Charlevoix-Saguenay type(SACS)
Bardet-Biedl syndrome 10(BBS10)
Cartilage-hair hypoplasia(RMRP)
LAMA2 muscular dystrophy(LAMA2)
Nonsyndromic hearing loss and deafness (DFNB) 77(LOXHD1)
Dyskeratosis congenita, RTEL1-related(RTEL1)
Fanconi anemia, Group A(FANCA)
Glycine encephalopathy, AMT-related(AMT)
Glycine encephalopathy / Nonketotic hyperglycinemia(GLDC)
Glycogen storage disease, type Ib / IIw(SLC37A4)
GLB1-related disorders(GLB1)
3-hydroxy-3-methylglutaryl-coA lyase deficiency(HMGCL)
Holocarboxylase synthetase deficiency(HLCS)
Homocystinuria, CBS-related(CBS)
Hydrolethalus syndrome(HYLS1)
GNE myopathy(GNE)
Infantile cerebral and cerebellar atrophy(MED17)
Isovaleric acidemia(IVD)
Junctional epidermolysis bullosa, LAMA3-related(LAMA3)
Junctional epidermolysis bullosa, LAMB3-related(LAMB3)
Junctional epidermolysis bullosa, LAMC2-related(LAMC2)
Autosomal recessive congenital ichthyosis 1(TGM1)
CEP290-related conditions(CEP290)
Mitochondrial complex IV deficiency, nuclear type 5 / Leigh syndrome, French-Canadian type(LRPPRC)
Lethal congenital contracture syndrome 1(GLE1)
Limb-girdle muscular dystrophy, type 4(SGCB)
Lysinuric protein intolerance(SLC7A7)
Maple syrup urine disease, type 2(DBT)
Methylmalonic aciduria, MMAA-related(MMAA)
Methylmalonic aciduria, MMAB-related(MMAB)
Methylmalonic aciduria, MUT-related(MMUT (AKA:MUT))
Mucopolysaccharidosis, type II / Hunter syndromee(IDS)
Mucopolysaccharidosis, type IIIB / Sanfilippo syndrome B(NAGLU)
Mucopolysaccharidosis, type IIIC / Sanfilippo syndrome C(HGSNAT)
Mucopolysaccharidosis, type IIID / Sanfilippo syndrome D(GNS)
Mucopolysaccharidosis, type VI / Maroteaux-Lamy syndrome(ARSB)
Neuronal ceroid lipofuscinosis, CLN6-related(CLN6)
Niemann-Pick disease, type C1(NPC1)
Pyruvate carboxylase deficiency(PC)
Retinitis pigmentosa 59(DHDDS)
Rhizomelic chondrodysplasia punctata, type 1(PEX7)
Sandhoff disease(HEXB)
Spondylothoracic dysostosis and spondylocostal dysostosis 2(MESP2)
Steroid-resistant nephrotic syndrome, type 2(NPHS2)
Tyrosine hydroxylase deficiency(TH)
Tyrosinemia, type II(TAT)
Usher syndrome, type 1B(MYO7A)
Usher syndrome, type 1C(USH1C)
Usher syndrome, type 1D(CDH23)
Zellweger spectrum disorders, PEX1-related(PEX1)
Zellweger spectrum disorders, PEX6-related(PEX6)
Alpha-thalassemia(HBA1/HBA2)
Beta hemoglobinopathies(HBB)
Bloom syndrome(BLM)
Canavan disease(ASPA)
Cystic fibrosis(CFTR)
Dihydrolipoamide dehydrogenase deficiency(DLD)
Familial dysautonomia(ELP1 (AKA:IKBKAP))
Familial hyperinsulinism, ABCC8-related(ABCC8)
Fanconi anemia, Group C(FANCC)
Fragile X syndromee(FMR1)
Gaucher disease(GBA)
Glycogen storage disease, type Ia(G6PC (AKA:G6PC1))
Joubert syndrome 2(TMEM216)
Maple syrup urine disease, type 1B(BCKDHB)
Mucolipidosis, type IV(MCOLN1)
Nemaline myopathy 2(NEB)
Niemann-Pick disease, types A/B(SMPD1)
Spinal muscular atrophy(SMN1)
Tay-Sachs disease(HEXA)
Usher syndrome, type 1F(PCDH15)
Usher syndrome, type 3A(CLRN1)
Fukuyama congenital muscular dystrophy (Walker-Warburg)(FKTN)
Abetalipoproteinemia(MTTP)
Adrenoleukodystrophy, X-linkede(ABCD1)
Argininosuccinic aciduria(ASL)
Ataxia-telangiectasia(ATM)
Autosomal recessive polycystic kidney disease(PKHD1)
Bardet-Biedl syndrome 1(BBS1)
Bardet-Biedl syndrome 2(BBS2)
Biotinidase deficiency(BTD)
Carnitine palmitoyltransferase II deficiency(CPT2)
Cerebrotendinous xanthomatosis(CYP27A1)
Citrullinemia, type I(ASS1)
Combined pituitary hormone deficiency, type 2(PROP1)
Congenital amegakaryocytic thrombocytopenia(MPL)
Congenital disorder of glycosylation, type Ia(PMM2)
Cystinosis(CTNS)
D-bifunctional protein deficiency(HSD17B4)
Factor XI deficiency / Hemophilia C(F11)
Familial Mediterranean fever(MEFV)
Galactosemia(GALT)
Glutaric acidemia, type I(GCDH)
Glycogen storage disease, type II / Pompe disease(GAA)
Glycogen storage disease, type III(AGL)
Glycogen storage disease, type IV / Adult polyglucosan body disease(GBE1)
GRACILE syndrome(BCS1L)
Hereditary fructose intolerance(ALDOB)
Hermansky-Pudlak syndrome, type 1(HPS1)
Hermansky-Pudlak syndrome, type 3(HPS3)
Hypophosphatasia(ALPL)
Krabbe disease(GALC)
Limb-girdle muscular dystrophy, type 2A(CAPN3)
Limb-girdle muscular dystrophy, type 3(SGCA)
Long chain 3-hydroxyacyl-coa dehydrogenase deficiency(HADHA)
Maple syrup urine disease, type 1A(BCKDHA)
Medium chain acyl-CoA dehydrogenase deficiency(ACADM)
Metachromatic leukodystrophy, ARSA-related(ARSA)
Combined methylmalonic aciduria and homocystinuria, cblC type / Cobalamin C deficiency(MMACHC)
Mucolipidosis II and mucolipidosis III alpha/beta(GNPTAB)
Mucopolysaccharidosis, type I / Hurler syndrome(IDUA)
Mucopolysaccharidosis, type IIIA / Sanfilippo syndrome A(SGSH)
Steroid resistant nephrotic syndrome, type 1(NPHS1)
Neuronal ceroid lipofuscinosis, CLN3-related(CLN3)
Neuronal ceroid lipofuscinosis, CLN5-related(CLN5)
Neuronal ceroid lipofuscinosis, CLN8-related(CLN8)
Neuronal ceroid lipofuscinosis, PPT1-related(PPT1)
Neuronal ceroid lipofuscinosis, TPP1-related(TPP1)
Nijmegen breakage syndrome(NBN)
Nonsyndromic hearing loss and deafness (DFNB) 1(GJB2)
Ornithine transcarbamylase deficiency, X-linkede(OTC)
Pendred syndrome(SLC26A4)
Phenylalanine hydroxylase deficiency(PAH)
Primary hyperoxaluria, type I(AGXT)
Propionic acidemia, PCCA-related(PCCA)
Propionic acidemia, PCCB-related(PCCB)
Sjögren-Larsson syndrome(ALDH3A2)
Skeletal dysplasias, SLC26A2-related(SLC26A2)
Smith-Lemli-Opitz syndrome(DHCR7)
Carnitine deficiency, systemic primary(SLC22A5)
Tyrosinemia, type I(FAH)
Usher syndrome, type 2A(USH2A)
Very long-chain acyl-CoA dehydrogenase deficiency(ACADVL)
Wilson disease(ATP7B)
Zellweger spectrum disorders, PEX2-related(PEX2)
Beta-ketothiolase deficiency(ACAT1)
3-methylcrotonyl-CoA carboxylase 1 deficiency(MCCC1)
3-methylcrotonyl-CoA carboxylase 2 deficiency(MCCC2)
6-pyruvoyl-tetrahydropterin synthase deficiency(PTS)
Adenosine deaminase deficiency(ADA)
Alpha-mannosidosis(MAN2B1)
Alport syndrome, COL4A3-related(COL4A3)
Alport syndrome, COL4A4-related(COL4A4)
Alport syndrome, COL4A5-related, X-linkede(COL4A5)
Agenesis of the corpus callosum with peripheral neuropathy(SLC12A6)
Arthrogryposis, mental retardation, and seizures(SLC35A3)
Aspartylglycosaminuria(AGA)
Menkes diseasee(ATP7A)
Autoimmune polyglandular syndrome, type 1(AIRE)
Spastic ataxia, Charlevoix-Saguenay type(SACS)
Bardet-Biedl syndrome 10(BBS10)
Cartilage-hair hypoplasia(RMRP)
LAMA2 muscular dystrophy(LAMA2)
Nonsyndromic hearing loss and deafness (DFNB) 77(LOXHD1)
Dyskeratosis congenita, RTEL1-related(RTEL1)
Fanconi anemia, Group A(FANCA)
Glycine encephalopathy, AMT-related(AMT)
Glycine encephalopathy / Nonketotic hyperglycinemia(GLDC)
Glycogen storage disease, type Ib / IIw(SLC37A4)
GLB1-related disorders(GLB1)
3-hydroxy-3-methylglutaryl-coA lyase deficiency(HMGCL)
Holocarboxylase synthetase deficiency(HLCS)
Homocystinuria, CBS-related(CBS)
Hydrolethalus syndrome(HYLS1)
GNE myopathy(GNE)
Infantile cerebral and cerebellar atrophy(MED17)
Isovaleric acidemia(IVD)
Junctional epidermolysis bullosa, LAMA3-related(LAMA3)
Junctional epidermolysis bullosa, LAMB3-related(LAMB3)
Junctional epidermolysis bullosa, LAMC2-related(LAMC2)
Autosomal recessive congenital ichthyosis 1(TGM1)
CEP290-related conditions(CEP290)
Mitochondrial complex IV deficiency, nuclear type 5 / Leigh syndrome, French-Canadian type(LRPPRC)
Lethal congenital contracture syndrome 1(GLE1)
Limb-girdle muscular dystrophy, type 4(SGCB)
Lysinuric protein intolerance(SLC7A7)
Maple syrup urine disease, type 2(DBT)
Methylmalonic aciduria, MMAA-related(MMAA)
Methylmalonic aciduria, MMAB-related(MMAB)
Methylmalonic aciduria, MUT-related(MMUT (AKA:MUT))
Mucopolysaccharidosis, type II / Hunter syndromee(IDS)
Mucopolysaccharidosis, type IIIB / Sanfilippo syndrome B(NAGLU)
Mucopolysaccharidosis, type IIIC / Sanfilippo syndrome C(HGSNAT)
Mucopolysaccharidosis, type IIID / Sanfilippo syndrome D(GNS)
Mucopolysaccharidosis, type VI / Maroteaux-Lamy syndrome(ARSB)
Neuronal ceroid lipofuscinosis, CLN6-related(CLN6)
Niemann-Pick disease, type C1(NPC1)
Pyruvate carboxylase deficiency(PC)
Retinitis pigmentosa 59(DHDDS)
Rhizomelic chondrodysplasia punctata, type 1(PEX7)
Sandhoff disease(HEXB)
Spondylothoracic dysostosis and spondylocostal dysostosis 2(MESP2)
Steroid-resistant nephrotic syndrome, type 2(NPHS2)
Tyrosine hydroxylase deficiency(TH)
Tyrosinemia, type II(TAT)
Usher syndrome, type 1B(MYO7A)
Usher syndrome, type 1C(USH1C)
Usher syndrome, type 1D(CDH23)
Zellweger spectrum disorders, PEX1-related(PEX1)
Zellweger spectrum disorders, PEX6-related(PEX6)
17-beta-hydroxysteroid dehydrogenase deficiency, type III(HSD17B3)
3-beta-hydroxysteroid dehydrogenase deficiency, type II(HSD3B2)
3-hydroxyacyl-CoA dehydrogenase deficiency(HADH)
3-methylglutaconic aciduria, type III / Costeff syndrome(OPA3)
Phosphoglycerate dehydrogenase deficiency(PHGDH)
Achromatopsia, CNGB3-related(CNGB3)
Acrodermatitis enteropathica(SLC39A4)
Action myoclonus renal failure syndrome(SCARB2)
Acute infantile liver failure(TRMU)
Peroxisomal acyl-CoA oxidase deficiency(ACOX1)
Congenital adrenal hyperplasia (CAH) due to 11-beta-hydroxylase deficiency(CYP11B1)
X-linked agammaglobulinemiae(BTK)
Aicardi-Goutieres syndrome 2(RNASEH2B)
Aicardi-Goutieres syndrome 3(RNASEH2C)
Aicardi-Goutieres syndrome 4(RNASEH2A)
Aicardi-Goutieres syndrome 5(SAMHD1)
Alpha-1 antitrypsin deficiency(SERPINA1)
Alpha-thalassemia intellectual disability syndrome, X-linkede(ATRX)
Alstrom Syndrome(ALMS1)
Amish infantile epilepsy syndrome(ST3GAL5)
Argininemia(ARG1)
Aromatase deficiency(CYP19A1)
PRPS1-related disorderse(PRPS1)
Asparagine synthetase deficiency(ASNS)
Ataxia with isolated vitamin E deficiency(TTPA)
Ataxia-telangiectasia-like disorder 1(MRE11)
Bardet-Biedl syndrome 4(BBS4)
Bardet-Biedl syndrome 6(MKKS)
Bardet-Biedl syndrome 7(BBS7)
Bardet-Biedl syndrome 8(TTC8)
Bardet-Biedl syndrome 9(BBS9)
Bardet-Biedl syndrome 12(BBS12)
Bare lymphocyte syndrome, type II(CIITA)
Barth syndromee(TAFAZZIN (AKA:TAZ))
Bartter syndrome, type 4A(BSND)
Bernard-Soulier syndrome, type A(GP1BA)
Bernard-Soulier syndrome, type C(GP9)
Beta-ureidopropionase deficiency(UPB1)
Bilateral frontoparietal polymicrogyria(ADGRG1)
Carbamoyl phosphate synthetase I deficiency(CPS1)
Carnitine palmitoyltransferase I deficiency(CPT1A)
Carnitine-acylcarnitine translocase deficiency(SLC25A20)
Carpenter syndrome(RAB23)
Neuronal ceroid lipofuscinosis, CTSD-related(CTSD)
Charcot-Marie-Tooth disease, type 1, X-linkede(GJB1)
Charcot-Marie-Tooth disease, type 4D(NDRG1)
Chediak-Higashi syndrome(LYST)
Progressive familial intrahepatic cholestasis 1 (PFIC1) and benign familial intrahepatic cholestasis 1 (BRIC1)(ATP8B1)
Cholestasis, progressive familial intrahepatic 4(TJP2)
Lysosomal acid lipase deficiency(LIPA)
Choreoacanthocytosis(VPS13A)
Choroideremia, X-linkede(CHM)
Chronic granulomatous disease 4(CYBA)
Chronic granulomatous disease, X-linkede(CYBB)
Ciliopathies, RPGRIP1L-related(RPGRIP1L)
Citrin deficiency / Citrullinemia, type II(SLC25A13)
Cockayne syndrome, type A(ERCC8)
Cohen syndrome(VPS13B)
Combined malonic and methylmalonic aciduria(ACSF3)
Combined oxidative phosphorylation deficiency 3(TSFM)
Combined oxidative phosphorylation deficiency 1(GFM1)
Combined oxidative phosphorylation deficiency 6e(AIFM1)
Combined pituitary hormone deficiency, type 3(LHX3)
Congenital adrenal hyperplasia (CAH) due to 17-alpha-hydroxylase deficiency(CYP17A1)
Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency(CYP21A2)
Congenital disorder of glycosylation, type Ib(MPI)
Congenital disorder of glycosylation, type Ic(ALG6)
Congenital ichthyosis, ABCA12-related(ABCA12)
Congenital insensitivity to pain with anhidrosis(NTRK1)
Lipoid congenital adrenal hyperplasia(STAR)
Congenital muscular dystrophy-dystroglycanopathy 1(POMT1)
Congenital myasthenic syndrome, CHAT-related(CHAT)
Congenital myasthenic syndrome, CHRNE-related(CHRNE)
Congenital myasthenic syndrome, DOK7-related(DOK7)
Congenital myasthenic syndrome, RAPSN-related(RAPSN)
Congenital neutropenia, HAX1-related(HAX1)
Severe congenital neutropenia 5(VPS45)
Corneal dystrophy and perceptive deafness syndrome(SLC4A11)
Corticosterone methyloxidase deficiency(CYP11B2)
L1 syndromee(L1CAM)
CRB1-related retinal dystrophies(CRB1)
Creatine Transporter Defect, SLC6A8-related, X-linked / Cerebral creatine deficiency syndromee(SLC6A8)
Cerebrooculofacioskeletal syndrome 1 / Cockayne syndrome, type B(ERCC6)
Usher syndrome, type 1J(CIB2)
Dent diseasee(CLCN5)
Desbuquois dysplasia, type I(CANT1)
Spastic tetraplegia, thin corpus callosum, and progressive microcephaly(SLC1A4)
Dihydropyrimidine dehydrogenase deficiency(DPYD)
Duchenne/Becker muscular dystrophy, X-linkede(DMD)
Dyskeratosis congenita, X-linkede(DKC1)
Dystrophic epidermolysis bullosa, COL7A1-related(COL7A1)
Ehlers-Danlos syndrome, dermatosparaxis type(ADAMTS2)
Ellis-van Creveld syndrome(EVC2)
Ellis-van Creveld syndrome(EVC)
Emery-Dreifuss muscular dystrophy, X-linkede(EMD)
Enhanced S-cone syndrome(NR2E3)
Ethylmalonic encephalopathy(ETHE1)
Fabry disease, X-linkede(GLA)
Familial hemophagocytic lymphohistiocytosis 2(PRF1)
Familial hemophagocytic lymphohistiocytosis 4(STX11)
Familial hemophagocytic lymphohistiocytosis 5(STXBP2)
Familial hypercholesterolemia, LDLRAP1-related(LDLRAP1)
Familial hypercholesterolemia, LDLR-related(LDLR)
Fanconi anemia, Group Be(FANCB)
Fanconi anemia, Group D2(FANCD2)
Fanconi anemia, Group E(FANCE)
Fanconi anemia, Group F(FANCF)
Fanconi anemia, Group G(FANCG)
Fanconi anemia, Group I(FANCI)
Fanconi anemia, Group L(FANCL)
Farber lipogranulomatosis(ASAH1)
Fumarate hydratase deficiency(FH)
GABA-transaminase deficiency(ABAT)
Galactosemia, type II / Galactokinase deficiency(GALK1)
Galactosialidosis(CTSA)
Gitelman syndrome(SLC12A3)
Glucose-6-phosphate dehydrogenase deficiencye(G6PD)
Multiple acyl-CoA dehydrogenase deficiency / Glutaric aciduria, type IIA(ETFA)
Multiple acyl-CoA dehydrogenase deficiency / Glutaric aciduria, type IIB(ETFDH)
Multiple acyl-CoA dehydrogenase deficiency / Glutaric aciduria, type IIC(ETFB)
Glycogen storage disease, type V(PYGM)
Glycogen storage disease, type VII(PFKM)
Guanidinoacetate methyltransferase deficiency(GAMT)
Factor IX deficiency / Hemophilia Be(F9)
MPV17-related mitochondrial DNA (mtDNA) maintenance defect(MPV17)
Hereditary hemochromatosis, type 2(HJV)
Hereditary hemochromatosis, type 3(TFR2)
TECPR2-related hereditary sensory and autonomic neuropathy with intellectual disability(TECPR2)
Hermansky-Pudlak syndrome, type 2(AP3B1)
Homocystinuria caused by methylenetetrahydrofolate reductase (MTHFR) deficiency(MTHFR)
Homocystinuria, type cblE(MTRR)
HPRT1-related disorderse(HPRT1)
Hermansky-Pudlak syndrome, type 4(HPS4)
Hyperphosphatemic familial tumoral calcinosis(GALNT3)
Hypohidrotic ectodermal dysplasia, X-linkede(EDA)
Immunodysregulation, polyendocrinopathy, and enteropathy, X-linkede(FOXP3)
PLA2G6-associated neurodegeneration(PLA2G6)
X-linked infantile spinal muscular atrophye(UBA1)
Johanson-Blizzard syndrome(UBR1)
Joubert syndrome 1(INPP5E)
Joubert syndrome 15(CEP41)
Joubert syndrome 21(CSPP1)
Joubert syndrome 25(CEP104)
Joubert syndrome 27(B9D1)
Joubert syndrome 3(AHI1)
Joubert syndrome 31(CEP120)
Joubert syndrome 34(B9D2)
Joubert syndrome 8(ARL13B)
Nephronophthisis 2(INVS)
NPHP1 nephronophthisis-related ciliopathies(NPHP1)
Juvenile retinoschisis, X-linkede(RS1)
Leber congenital amaurosis 5(LCA5)
Leber congenital amaurosis 2(RPE65)
Leber congenital amaurosis 13(RDH12)
Leukoencephalopathy with vanishing white matter(EIF2B5)
Limb-girdle muscular dystrophy, type 2B(DYSF)
Limb-girdle muscular dystrophy, type 5(SGCG)
Limb-girdle muscular dystrophy, type 6(SGCD)
Limb-girdle muscular dystrophy, type 2I / Muscular dystrophy-dystroglycanopathy 5(FKRP)
Lipoprotein lipase deficiency(LPL)
X-linked developmental disorders, ARX-relatede(ARX)
Lowe syndrome, X-linkede(OCRL)
Malonyl-CoA decarboxylase deficiency(MLYCD)
Joubert syndrome 9(CC2D2A)
MEDNIK syndrome(AP1S1)
Megalencephalic leukoencephalopathy with subcortical cysts(MLC1)
Metachromatic leukodystrophy due to saposin B deficiency(PSAP)
Combined methylmalonic aciduria and homocystinuria, cblD type / Cobalamin D deficiency(MMADHC)
Micropthalmia / Anopthalmia(VSX2)
Mitochondrial complex I deficiency, nuclear type 16(NDUFAF5)
Mitochondrial complex I deficiency, nuclear type 9(NDUFS6)
Mitochondrial complex I deficiency, nuclear type 1(NDUFS4)
Mitochondrial complex I deficiency, nuclear type 17(NDUFAF6)
Mitochondrial complex IV deficiency, nuclear type 12(PET100)
Myopathy, lactic acidosis, and sideroblastic anemia(PUS1)
Mitochondrial trifunctional protein deficiency, HADHB-related(HADHB)
MKS1-related disorders(MKS1)
Molybdenum cofactor deficiency of complementation group A(MOCS1)
Mucolipidosis III gamma(GNPTG)
Mucopolysaccharidosis, type IVA / Morquio syndrome(GALNS)
Mucopolysaccharidosis, type VII / Sly syndrome(GUSB)
Mucopolysaccharidosis, type IX / Hyaluronidase deficiency(HYAL1)
Mulibrey nanism(TRIM37)
Multiple pterygium syndrome, lethal type(CHRNG)
Multiple sulfatase deficiency(SUMF1)
Muscular dystrophy-dystroglycanopathy 3(POMGNT1)
Muscular dystrophy-dystroglycanopathy 7(CRPPA)
Muscular dystrophy-dystroglycanopathy 6(LARGE1)
Muscular dystrophy-dystroglycanopathy 2(POMT2)
Congenital myasthenic syndrome, COLQ-related(COLQ)
Mitochondrial neurogastrointestinal encephalopathy(TYMP)
X-linked myotubular myopathye(MTM1)
Nephrogenic diabetes insipidus(AQP2)
Steroid-resistant nephrotic syndrome, type 3(PLCE1)
Neuronal ceroid lipofuscinosis, MFSD8-related(MFSD8)
Niemann-Pick disease, type C2(NPC2)
N-acetylglutamate synthase deficiency(NAGS)
Nonsyndromic hearing loss and deafness (DFNB) 3(MYO15A)
Odonto-onycho-dermal dysplasia / Schopf-Schulz-Passarge syndrome(WNT10A)
Omenn syndrome(DCLRE1C)
Severe combined immunodeficiency, RAG2-related(RAG2)
Ornithine aminotransferase deficiency(OAT)
Ornithine translocase deficiency(SLC25A15)
Joubert syndrome 17(CPLANE1)
Orofaciodigital syndrome XIV(C2CD3)
Osteopetrosis, infantile malignant, TCIRG1-related(TCIRG1)
Perlman syndrome(DIS3L2)
Zellweger spectrum disorders, PEX12-related(PEX12)
POLG-related disorders(POLG)
Pontocerebellar hypoplasia, type 1B(EXOSC3)
Pontocerebellar hypoplasia, type 2B(TSEN2)
Pontocerebellar hypoplasia, type 4 and 2A(TSEN54)
Pontocerebellar hypoplasia, type 6(RARS2)
Pontocerebellar hypoplasia, type 2E(VPS53)
Pontocerebellar hypoplasia, type 1A(VRK1)
Primary ciliary dyskinesia, DNAH5-related(DNAH5)
Primary ciliary dyskinesia, DNAI1-related(DNAI1)
Primary ciliary dyskinesia, DNAI2-related(DNAI2)
Primary congenital glaucoma(CYP1B1)
Primary hyperoxaluria, type II(GRHPR)
Primary hyperoxaluria, type III(HOGA1)
Progressive cerebello-cerebral atrophy(SEPSECS)
Progressive familial intrahepatic cholestastasis, type 2(ABCB11)
Prolidase deficiency(PEPD)
Pseudocholinesterase deficiency(BCHE)
Pseudoxanthoma elasticum(ABCC6)
Pycnodysostosis(CTSK)
Pyridoxine-dependent epilepsy(ALDH7A1)
Pyruvate dehydrogenase E1-alpha deficiencye(PDHA1)
Pyruvate dehydrogenase E1-beta deficiency(PDHB)
Recurrent metabolic crises with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration(TANGO2)
Refsum disease(PHYH)
Renal tubular acidosis(SLC4A4)
Renal tubular acidosis and deafness, ATP6V1B1-related(ATP6V1B1)
NPHP3 nephronophthisis-related ciliopathies(NPHP3)
Retinitis pigmentosa 25(EYS)
Retinitis pigmentosa 26(CERKL)
Retinitis pigmentosa 28(FAM161A)
Rhizomelic chondrodysplasia punctata, type 2(GNPAT)
Rhizomelic chondrodysplasia punctata, type 3(AGPS)
Mitochondrial complex I deficiency, ACAD9-related(ACAD9)
Roberts-SC phocomelia syndrome(ESCO2)
Free sialic acid storage disorders(SLC17A5)
Schimke immunoosseous dysplasia(SMARCAL1)
NPHP4 nephronophthisis-related ciliopathies(NPHP4)
Severe combined immunodeficiency, X-linkede(IL2RG)
Shwachman-Diamond syndrome(SBDS)
Sialidosis(NEU1)
Spastic paraplegia, type 15(ZFYVE26)
WWOX deficiency(WWOX)
Steel syndrome(COL27A1)
Stuve-Wiedemann syndrome(LIFR)
Severe combined immunodeficiency, RAG1-related(RAG1)
Trichohepatoenteric syndrome 1(TTC37)
ERCC2-related conditions(ERCC2)
Triple A syndrome(AAAS)
Usher syndrome, type 2C(ADGRV1)
Vitamin D-dependent rickets, type 1A(CYP27B1)
Werner syndrome(WRN)
Wiskott-Aldrich syndrome, X-linkede(WAS)
Wolcott-Rallison syndrome(EIF2AK3)
Xeroderma pigmentosum, group A(XPA)
Xeroderma pigmentosum, group C(XPC)
X-linked chondrodysplasia punctata 1e(ARSL)
X-linked congenital adrenal hypoplasiae(NR0B1)
X-linked heterotaxy-1e(ZIC3)
X-Linked Hyper IgM Syndromee(CD40LG)
DCX-related disorderse(DCX)
Zellweger spectrum disorders, PEX26-related(PEX26)
Zellweger spectrum disorders, PEX10-related(PEX10)
The below disease conditions are included in the QHerit panel. If there’s an interest in screening for a specific disorder, Quest also offers single-gene screening of these disease conditions.b,cPlease refer to the Gene test code column for ordering information.
DISEASE CONDITIONS
GENE
Gene test codeb,c
DISEASE CONDITION
Alpha-thalassemia
GENE
HBA1/HBA2
Gene test codeb,c
11175
DISEASE CONDITION
Beta-hemoglobinopathies (including sickle cell disease)
GENE
HBB
Gene test codeb,c
14974
DISEASE CONDITION
Bloom syndrome
GENE
BLM
Gene test codeb,c
90872
DISEASE CONDITION
Canavan disease
GENE
ASPA
Gene test codeb,c
90905
DISEASE CONDITION
Cystic fibrosis
GENE
CFTR
Gene test codeb,c
92068
DISEASE CONDITION
Dihydrolipoamide dehydrogenase deficiency
GENE
DLD
Gene test codeb,c
92046
DISEASE CONDITION
Familial dysautonomia
GENE
IKBKAP
Gene test codeb,c
90912
DISEASE CONDITION
Familial hyperinsulinism, ABCC8-related
GENE
ABCC8
Gene test codeb,c
92045
DISEASE CONDITION
Fanconi anemia, type C
GENE
FANCC
Gene test codeb,c
90897
DISEASE CONDITION
Fragile X syndromed
GENE
FMR1
Gene test codeb,c
16313
DISEASE CONDITION
Gaucher disease
GENE
GBA
Gene test codeb,c
90907
DISEASE CONDITION
Glycogen storage disease, type 1A
GENE
G6PC
Gene test codeb,c
90915
DISEASE CONDITION
Joubert syndrome 2
GENE
TMEM216
Gene test codeb,c
92050
DISEASE CONDITION
Maple syrup urine disease, 1B
GENE
BCKDHB
Gene test codeb,c
90909
DISEASE CONDITION
Mucolipidosis, type 4
GENE
MCOLN1
Gene test codeb,c
90899
DISEASE CONDITION
Nemaline myopathy
GENE
NEB
Gene test codeb,c
92055
DISEASE CONDITION
Niemann-Pick disease, types A & B
GENE
SMPD1
Gene test codeb,c
90893
DISEASE CONDITION
Spinal muscular atrophy
GENE
SMN
Gene test codeb,c
39445
DISEASE CONDITION
Tay-Sachs disease
GENE
HEXA
Gene test codeb,c
90903
DISEASE CONDITION
Usher syndrome, type 1F
GENE
PCDH15
Gene test codeb,c
92047
DISEASE CONDITION
Usher syndrome, type 3A
GENE
CLRN1
Gene test codeb,c
92048
DISEASE CONDITION
Walker-Warburg syndrome
GENE
FKTN
Gene test codeb,c
92051
c Panel components for males do not include specified X-linked diseases.
e Designated X-linked disease.
While we offer a comprehensive testing menu, some patients may have an interest in screening for a specific disorder, such as cystic fibrosis. For these patients, Quest Diagnostics offers single-gene screening. Consultation available on genetic test selection and results interpretation 1.866.GENE.INFO (1.866.436.3463).
Please note that Quest offers a variety of single-gene and gene panel testing. For the genetic panel noted in this document, there may be single-gene tests or smaller panels that may be applicable for your patient. Refer to the Quest Diagnostics Test Directory for further information.
*QHerit, QHerit Plus, QHerit Extended, QHerit 421 and QHerit 381 are carrier “screening” tests, and they screen for variations in genes linked to certain health disorders, which can be passed from parents to children. QHerit screens 24 genes; QHerit Plus screens 85 genes, QHerit Extended screens 150 genes, QHerit 421 screens 421 genes and QHerit 381 screens 381 genes. For a full list of genes that each panel in the QHerit family screens, visit the Quest Diagnostics Test Directory. If the results from any panel in the QHerit family suggest that a patient may be a carrier of a gene variation that can cause a health disorder in her offspring, it is recommended that her reproductive partner be offered genetic screening, and that genetic counseling be provided. Pregnancy management decisions should not be based on the results of these screening tests alone. As with any test, there may be false positives or false negatives. The positive predictive value of the screening test varies by genetic variation, and may be lower for rare conditions. Each panel in the QHerit family is a laboratory-developed test that has been developed and validated pursuant to the Clinical Laboratory Improvements Amendments of 1988 (CLIA) and, as such, it has not been reviewed by FDA.
Test codes may vary by location. Please contact your local laboratory for more information.
Image content features models and is intended for illustrative purposes only.
a Based on Quest Diagnostics 2021 fiscal year national claims analysis.
b While we offer comprehensive testing, some patients may have an interest in screening for a specific disorder, such as cystic fibrosis. For these patients, Quest Diagnostics offers single-gene screening. Consultation available on genetic test selection and results interpretation: 1.866.GENE.INFO (1.866.436.3463).
c Please note that Quest offers a variety of single gene and gene panel testing. For the genetic panel noted in this document, there may be single gene tests or smaller panels that may be applicable for your patient. Panel and Profile components may be ordered separately. Refer to the Quest Diagnostics Test Directory for further information: https://testdirectory.questdiagnostics.com/test/home.
d Designated X-linked diseases.
* QHerit is a carrier “screening” test, and it screens for variations in genes linked to certain health disorders, which can be passed from parents to children. For a full list of all 22 genes that QHerit screens, visit QHerit.com. If QHerit results suggest that a patient may be a carrier of a gene variation that can cause a health disorder in her offspring, it is recommended that her reproductive partner be offered genetic screening, and that genetic counseling be provided. Pregnancy management decisions should not be based on the results of QHerit alone. As with any test, there may be false positives or false negatives. The positive predictive value of the screening test varies by genetic variation, and may be lower for rare conditions. QHerit is a laboratory developed test that has been developed and validated, pursuant to the Clinical Laboratory Improvements Amendments of 1988 (CLIA), and as such it has not been reviewed by FDA.
Test codes may vary by location. Please contact your local laboratory for more information.
Image content features models and is intended for illustrative purposes only.
CertifiedBoard-certified counselors are available to help with test selection and results interpretation 1.866.GENE.INFO (1.866.436.3463).
For assistance with questions about the testing process or locations, call 1.866.MYQUEST (1.866.697.8378)
Call 1.866.MYQUEST
(1.866.697.8378)
The brochure will be downloaded automatically.